Form 8-K - Current report:
SEC Accession No. 0001356576-24-000062
Filing Date
2024-10-30
Accepted
2024-10-30 16:38:08
Documents
13
Period of Report
2024-10-30
Items
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 8-K supn-20241030.htm   iXBRL 8-K 25823
  Complete submission text file 0001356576-24-000062.txt   148669

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT supn-20241030.xsd EX-101.SCH 1798
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT supn-20241030_lab.xml EX-101.LAB 21884
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT supn-20241030_pre.xml EX-101.PRE 12522
15 EXTRACTED XBRL INSTANCE DOCUMENT supn-20241030_htm.xml XML 2727
Mailing Address 9715 KEY WEST AVENUE ROCKVILLE MD 20850
Business Address 9715 KEY WEST AVENUE ROCKVILLE MD 20850 301-838-2500
SUPERNUS PHARMACEUTICALS, INC. (Filer) CIK: 0001356576 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35518 | Film No.: 241410919
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)